|
2OV5
Crystal structure of the KPC-2 carbapenemase
Deposited 2007-02-13
|
Different construct
Different ligand/ion
Different experimental conditions
Different structure-quality metrics
|
Assembly 1
Protein monomer
Monomer;Protein × 1
PDB declaration: monomeric
|
Chain A
30–290(261 aa)
|
Not recorded
|
BCN BICINE × 1
|
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, SITTING DROP;pH 9;293 K;16% PEG6000, 0.1M bicine, pH 9, VAPOR DIFFUSION, SITTING DROP, temperature 293K
|
Resolution 1.85 Å
R-free 0.190
|
|
2OV5
Crystal structure of the KPC-2 carbapenemase
Deposited 2007-02-13
|
Different construct
Different ligand/ion
Different experimental conditions
Different structure-quality metrics
|
Assembly 2
Protein monomer
Monomer;Protein × 1
PDB declaration: monomeric
|
Chain B
30–290(261 aa)
|
Not recorded
|
BCN BICINE × 1
|
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, SITTING DROP;pH 9;293 K;16% PEG6000, 0.1M bicine, pH 9, VAPOR DIFFUSION, SITTING DROP, temperature 293K
|
Resolution 1.85 Å
R-free 0.190
|
|
2OV5
Crystal structure of the KPC-2 carbapenemase
Deposited 2007-02-13
|
Different construct
Different ligand/ion
Different experimental conditions
Different structure-quality metrics
|
Assembly 3
Protein monomer
Monomer;Protein × 1
PDB declaration: monomeric
|
Chain C
30–290(261 aa)
|
Not recorded
|
BCN BICINE × 1
|
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, SITTING DROP;pH 9;293 K;16% PEG6000, 0.1M bicine, pH 9, VAPOR DIFFUSION, SITTING DROP, temperature 293K
|
Resolution 1.85 Å
R-free 0.190
|
|
3E2K
Crystal Structure of the KPC-2 Beta-lactamase/Beta-lactamase inhibitor protein (BLIP)
Deposited 2008-08-05
|
Different construct
Different mutation/modification
Different oligomeric state
Different ligand/ion
Different experimental conditions
Different structure-quality metrics
|
Assembly 1
Protein heterocomplex
Heteromer;Protein × 2
PDB declaration: dimeric
|
Chain A
30–293(264 aa)
Fragment:UNP residues 30-293
|
Mutation:G175S
|
No recorded non-water small molecule
|
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, HANGING DROP;pH 4.5;290 K;20% PEG 8000, 4% ethylene glycol, 100mM citrate, pH 4.5, VAPOR DIFFUSION, HANGING DROP, temperature 290K
|
Resolution 2.10 Å
R-free 0.234
|
|
3E2K
Crystal Structure of the KPC-2 Beta-lactamase/Beta-lactamase inhibitor protein (BLIP)
Deposited 2008-08-05
|
Different construct
Different mutation/modification
Different oligomeric state
Different ligand/ion
Different experimental conditions
Different structure-quality metrics
|
Assembly 2
Protein heterocomplex
Heteromer;Protein × 2
PDB declaration: dimeric
|
Chain B
30–293(264 aa)
Fragment:UNP residues 30-293
|
Mutation:G175S
|
No recorded non-water small molecule
|
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, HANGING DROP;pH 4.5;290 K;20% PEG 8000, 4% ethylene glycol, 100mM citrate, pH 4.5, VAPOR DIFFUSION, HANGING DROP, temperature 290K
|
Resolution 2.10 Å
R-free 0.234
|
|
3E2L
Crystal Structure of the KPC-2 Beta-lactamase/Beta-lactamase inhibitor protein (BLIP)
Deposited 2008-08-05
|
Different construct
Different mutation/modification
Different oligomeric state
Different ligand/ion
Different experimental conditions
Different structure-quality metrics
|
Assembly 1
Protein heterocomplex
Heteromer;Protein × 2
PDB declaration: dimeric
|
Chain A
30–293(264 aa)
Fragment:UNP residues 30-293
|
Mutation:G175S
Non-standard monomer:Yes (specific site not provided by mmCIF)
|
No recorded non-water small molecule
|
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, HANGING DROP;pH 5;290 K;20% PEG 8000, 6% ethylene glycol, 100mM citrate, pH 5.0, VAPOR DIFFUSION, HANGING DROP, temperature 290K
|
Resolution 1.87 Å
R-free 0.213
|
|
3E2L
Crystal Structure of the KPC-2 Beta-lactamase/Beta-lactamase inhibitor protein (BLIP)
Deposited 2008-08-05
|
Different construct
Different mutation/modification
Different oligomeric state
Different ligand/ion
Different experimental conditions
Different structure-quality metrics
|
Assembly 2
Protein heterocomplex
Heteromer;Protein × 2
PDB declaration: dimeric
|
Chain B
30–293(264 aa)
Fragment:UNP residues 30-293
|
Mutation:G175S
Non-standard monomer:Yes (specific site not provided by mmCIF)
|
No recorded non-water small molecule
|
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, HANGING DROP;pH 5;290 K;20% PEG 8000, 6% ethylene glycol, 100mM citrate, pH 5.0, VAPOR DIFFUSION, HANGING DROP, temperature 290K
|
Resolution 1.87 Å
R-free 0.213
|
|
6J8Q
Serine Beta-Lactamase KPC-2 in Complex with Dual MBL/SBL Inhibitor WL-001
Deposited 2019-01-21
|
Different ligand/ion
Different experimental conditions
Different structure-quality metrics
|
Assembly 1
Protein monomer
Monomer;Protein × 1
PDB declaration: monomeric
|
Chain A
26–289(264 aa)
|
Not recorded
|
BHU [[(2S)-2-methyl-3-sulfanyl-propanoyl]amino]methylboronic acid × 1
PEG DI(HYDROXYETHYL)ETHER × 7
ACY ACETIC ACID × 2
|
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, HANGING DROP;pH 4.5;293 K;32% to 35% PEG 8000, 0.1M lithium sulphate, 0.05M sodium acetate (pH 4.5)
|
Resolution 1.79 Å
R-free 0.205
|
|
6J8Q
Serine Beta-Lactamase KPC-2 in Complex with Dual MBL/SBL Inhibitor WL-001
Deposited 2019-01-21
|
Different ligand/ion
Different experimental conditions
Different structure-quality metrics
|
Assembly 2
Protein monomer
Monomer;Protein × 1
PDB declaration: monomeric
|
Chain B
26–289(264 aa)
|
Not recorded
|
BHU [[(2S)-2-methyl-3-sulfanyl-propanoyl]amino]methylboronic acid × 1
PEG DI(HYDROXYETHYL)ETHER × 4
ACY ACETIC ACID × 2
|
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, HANGING DROP;pH 4.5;293 K;32% to 35% PEG 8000, 0.1M lithium sulphate, 0.05M sodium acetate (pH 4.5)
|
Resolution 1.79 Å
R-free 0.205
|
|
6J8Q
Serine Beta-Lactamase KPC-2 in Complex with Dual MBL/SBL Inhibitor WL-001
Deposited 2019-01-21
|
Different ligand/ion
Different experimental conditions
Different structure-quality metrics
|
Assembly 3
Protein monomer
Monomer;Protein × 1
PDB declaration: monomeric
|
Chain C
26–289(264 aa)
|
Not recorded
|
BHU [[(2S)-2-methyl-3-sulfanyl-propanoyl]amino]methylboronic acid × 1
PEG DI(HYDROXYETHYL)ETHER × 2
ACY ACETIC ACID × 1
SO4 SULFATE ION × 1
|
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, HANGING DROP;pH 4.5;293 K;32% to 35% PEG 8000, 0.1M lithium sulphate, 0.05M sodium acetate (pH 4.5)
|
Resolution 1.79 Å
R-free 0.205
|
|
6J8Q
Serine Beta-Lactamase KPC-2 in Complex with Dual MBL/SBL Inhibitor WL-001
Deposited 2019-01-21
|
Different ligand/ion
Different experimental conditions
Different structure-quality metrics
|
Assembly 4
Protein monomer
Monomer;Protein × 1
PDB declaration: monomeric
|
Chain D
26–289(264 aa)
|
Not recorded
|
BHU [[(2S)-2-methyl-3-sulfanyl-propanoyl]amino]methylboronic acid × 1
PEG DI(HYDROXYETHYL)ETHER × 3
ACY ACETIC ACID × 1
SO4 SULFATE ION × 1
|
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, HANGING DROP;pH 4.5;293 K;32% to 35% PEG 8000, 0.1M lithium sulphate, 0.05M sodium acetate (pH 4.5)
|
Resolution 1.79 Å
R-free 0.205
|
|
6JN3
Serine Beta-Lactamase KPC-2 in Complex with Dual MBL/SBL Inhibitor MS05
Deposited 2019-03-13
|
Different ligand/ion
Different experimental conditions
Different structure-quality metrics
|
Assembly 1
Protein monomer
Monomer;Protein × 1
PDB declaration: monomeric
|
Chain A
26–289(264 aa)
|
Not recorded
|
BX6 [(1R)-1-[[(2S)-2-methyl-3-sulfanyl-propanoyl]amino]-2-phenyl-ethyl]boronic acid × 1
PEG DI(HYDROXYETHYL)ETHER × 1
ACY ACETIC ACID × 2
|
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, HANGING DROP;pH 4.5;293 K;32-35% PEG 8000, 0.1M lithium sulphate, 0.05M sodium acetate (pH 4.5)
|
Resolution 2.22 Å
R-free 0.201
|
|
6JN3
Serine Beta-Lactamase KPC-2 in Complex with Dual MBL/SBL Inhibitor MS05
Deposited 2019-03-13
|
Different ligand/ion
Different experimental conditions
Different structure-quality metrics
|
Assembly 2
Protein monomer
Monomer;Protein × 1
PDB declaration: monomeric
|
Chain B
26–289(264 aa)
|
Not recorded
|
BX6 [(1R)-1-[[(2S)-2-methyl-3-sulfanyl-propanoyl]amino]-2-phenyl-ethyl]boronic acid × 1
PEG DI(HYDROXYETHYL)ETHER × 3
ACY ACETIC ACID × 1
|
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, HANGING DROP;pH 4.5;293 K;32-35% PEG 8000, 0.1M lithium sulphate, 0.05M sodium acetate (pH 4.5)
|
Resolution 2.22 Å
R-free 0.201
|
|
6JN3
Serine Beta-Lactamase KPC-2 in Complex with Dual MBL/SBL Inhibitor MS05
Deposited 2019-03-13
|
Different ligand/ion
Different experimental conditions
Different structure-quality metrics
|
Assembly 3
Protein monomer
Monomer;Protein × 1
PDB declaration: monomeric
|
Chain C
26–289(264 aa)
|
Not recorded
|
BX6 [(1R)-1-[[(2S)-2-methyl-3-sulfanyl-propanoyl]amino]-2-phenyl-ethyl]boronic acid × 1
PEG DI(HYDROXYETHYL)ETHER × 1
ACY ACETIC ACID × 2
|
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, HANGING DROP;pH 4.5;293 K;32-35% PEG 8000, 0.1M lithium sulphate, 0.05M sodium acetate (pH 4.5)
|
Resolution 2.22 Å
R-free 0.201
|
|
6JN3
Serine Beta-Lactamase KPC-2 in Complex with Dual MBL/SBL Inhibitor MS05
Deposited 2019-03-13
|
Different ligand/ion
Different experimental conditions
Different structure-quality metrics
|
Assembly 4
Protein monomer
Monomer;Protein × 1
PDB declaration: monomeric
|
Chain D
26–289(264 aa)
|
Not recorded
|
BX6 [(1R)-1-[[(2S)-2-methyl-3-sulfanyl-propanoyl]amino]-2-phenyl-ethyl]boronic acid × 1
PEG DI(HYDROXYETHYL)ETHER × 1
ACY ACETIC ACID × 2
|
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, HANGING DROP;pH 4.5;293 K;32-35% PEG 8000, 0.1M lithium sulphate, 0.05M sodium acetate (pH 4.5)
|
Resolution 2.22 Å
R-free 0.201
|
|
6JN4
Serine Beta-Lactamase KPC-2 in Complex with Dual MBL/SBL Inhibitor WL-001
Deposited 2019-03-13
|
Different ligand/ion
Different experimental conditions
Different structure-quality metrics
|
Assembly 1
Protein monomer
Monomer;Protein × 1
PDB declaration: monomeric
|
Chain A
26–289(264 aa)
|
Not recorded
|
BX9 [(R)-(4-fluorophenyl)-[[(2S)-2-methyl-3-sulfanyl-propanoyl]amino]methyl]boronic acid × 1
ACT ACETATE ION × 1
ACY ACETIC ACID × 2
PEG DI(HYDROXYETHYL)ETHER × 2
|
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, HANGING DROP;pH 4.5;293 K;0.1M Lithium Sulphate, 0.05M Sodium Acetate (pH 4.5), 32-35 % (v/v) Polyethylene glycol 8000
|
Resolution 1.90 Å
R-free 0.221
|
|
6JN4
Serine Beta-Lactamase KPC-2 in Complex with Dual MBL/SBL Inhibitor WL-001
Deposited 2019-03-13
|
Different ligand/ion
Different experimental conditions
Different structure-quality metrics
|
Assembly 2
Protein monomer
Monomer;Protein × 1
PDB declaration: monomeric
|
Chain B
26–289(264 aa)
|
Not recorded
|
BX9 [(R)-(4-fluorophenyl)-[[(2S)-2-methyl-3-sulfanyl-propanoyl]amino]methyl]boronic acid × 1
ACT ACETATE ION × 1
ACY ACETIC ACID × 1
PEG DI(HYDROXYETHYL)ETHER × 4
|
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, HANGING DROP;pH 4.5;293 K;0.1M Lithium Sulphate, 0.05M Sodium Acetate (pH 4.5), 32-35 % (v/v) Polyethylene glycol 8000
|
Resolution 1.90 Å
R-free 0.221
|
|
6JN4
Serine Beta-Lactamase KPC-2 in Complex with Dual MBL/SBL Inhibitor WL-001
Deposited 2019-03-13
|
Different ligand/ion
Different experimental conditions
Different structure-quality metrics
|
Assembly 3
Protein monomer
Monomer;Protein × 1
PDB declaration: monomeric
|
Chain C
26–289(264 aa)
|
Not recorded
|
BX9 [(R)-(4-fluorophenyl)-[[(2S)-2-methyl-3-sulfanyl-propanoyl]amino]methyl]boronic acid × 1
ACT ACETATE ION × 1
ACY ACETIC ACID × 1
PEG DI(HYDROXYETHYL)ETHER × 2
|
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, HANGING DROP;pH 4.5;293 K;0.1M Lithium Sulphate, 0.05M Sodium Acetate (pH 4.5), 32-35 % (v/v) Polyethylene glycol 8000
|
Resolution 1.90 Å
R-free 0.221
|
|
6JN4
Serine Beta-Lactamase KPC-2 in Complex with Dual MBL/SBL Inhibitor WL-001
Deposited 2019-03-13
|
Different ligand/ion
Different experimental conditions
Different structure-quality metrics
|
Assembly 4
Protein monomer
Monomer;Protein × 1
PDB declaration: monomeric
|
Chain D
26–289(264 aa)
|
Not recorded
|
BX9 [(R)-(4-fluorophenyl)-[[(2S)-2-methyl-3-sulfanyl-propanoyl]amino]methyl]boronic acid × 1
ACT ACETATE ION × 1
ACY ACETIC ACID × 1
|
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, HANGING DROP;pH 4.5;293 K;0.1M Lithium Sulphate, 0.05M Sodium Acetate (pH 4.5), 32-35 % (v/v) Polyethylene glycol 8000
|
Resolution 1.90 Å
R-free 0.221
|
|
7E9A
Crystal structure of KPC-2 in complex with (S)-2-(1-hydroxy-1,3-dihydrobenzo[c][1,2]oxaborol-3-yl)acrylic acid (4a-(S))
Deposited 2021-03-03
|
Different ligand/ion
Different experimental conditions
Different structure-quality metrics
|
Assembly 1
Protein monomer
Monomer;Protein × 1
PDB declaration: monomeric
|
Chain A
26–289(264 aa)
|
Not recorded
|
J00 2-[(3S)-1-oxidanyl-3H-2,1-benzoxaborol-3-yl]prop-2-enoic acid × 1
ACY ACETIC ACID × 1
PEG DI(HYDROXYETHYL)ETHER × 1
GOL GLYCEROL × 3
|
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, HANGING DROP;293 K;32-35% PEG 8000, 0.1M lithium sulphate, 0.05M sodium acetate (pH 4.5)
|
Resolution 2.25 Å
R-free 0.221
|
|
7E9A
Crystal structure of KPC-2 in complex with (S)-2-(1-hydroxy-1,3-dihydrobenzo[c][1,2]oxaborol-3-yl)acrylic acid (4a-(S))
Deposited 2021-03-03
|
Different ligand/ion
Different experimental conditions
Different structure-quality metrics
|
Assembly 2
Protein monomer
Monomer;Protein × 1
PDB declaration: monomeric
|
Chain B
26–289(264 aa)
|
Not recorded
|
J00 2-[(3S)-1-oxidanyl-3H-2,1-benzoxaborol-3-yl]prop-2-enoic acid × 1
PEG DI(HYDROXYETHYL)ETHER × 4
GOL GLYCEROL × 1
|
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, HANGING DROP;293 K;32-35% PEG 8000, 0.1M lithium sulphate, 0.05M sodium acetate (pH 4.5)
|
Resolution 2.25 Å
R-free 0.221
|
|
7E9A
Crystal structure of KPC-2 in complex with (S)-2-(1-hydroxy-1,3-dihydrobenzo[c][1,2]oxaborol-3-yl)acrylic acid (4a-(S))
Deposited 2021-03-03
|
Different ligand/ion
Different experimental conditions
Different structure-quality metrics
|
Assembly 3
Protein monomer
Monomer;Protein × 1
PDB declaration: monomeric
|
Chain C
26–289(264 aa)
|
Not recorded
|
J00 2-[(3S)-1-oxidanyl-3H-2,1-benzoxaborol-3-yl]prop-2-enoic acid × 1
ACY ACETIC ACID × 1
PEG DI(HYDROXYETHYL)ETHER × 4
GOL GLYCEROL × 1
|
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, HANGING DROP;293 K;32-35% PEG 8000, 0.1M lithium sulphate, 0.05M sodium acetate (pH 4.5)
|
Resolution 2.25 Å
R-free 0.221
|
|
7E9A
Crystal structure of KPC-2 in complex with (S)-2-(1-hydroxy-1,3-dihydrobenzo[c][1,2]oxaborol-3-yl)acrylic acid (4a-(S))
Deposited 2021-03-03
|
Different ligand/ion
Different experimental conditions
Different structure-quality metrics
|
Assembly 4
Protein monomer
Monomer;Protein × 1
PDB declaration: monomeric
|
Chain D
26–289(264 aa)
|
Not recorded
|
J00 2-[(3S)-1-oxidanyl-3H-2,1-benzoxaborol-3-yl]prop-2-enoic acid × 1
ACY ACETIC ACID × 1
PEG DI(HYDROXYETHYL)ETHER × 1
GOL GLYCEROL × 1
|
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, HANGING DROP;293 K;32-35% PEG 8000, 0.1M lithium sulphate, 0.05M sodium acetate (pH 4.5)
|
Resolution 2.25 Å
R-free 0.221
|
|
7LJK
Crystal structure of the deacylation deficient KPC-2 F72Y mutant
Deposited 2021-01-29
|
Different mutation/modification
Different ligand/ion
Different experimental conditions
Different structure-quality metrics
|
Assembly 1
Protein monomer
Monomer;Protein × 1
PDB declaration: monomeric
|
Chain A
26–289(264 aa)
|
Mutation:F72Y
|
No recorded non-water small molecule
|
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, HANGING DROP;pH 4.5;298 K;25% PEG 8,000, 0.1M KsCN, 0.1M Sodium Acetate pH:4.5
|
Resolution 1.81 Å
R-free 0.197
|
|
7LJK
Crystal structure of the deacylation deficient KPC-2 F72Y mutant
Deposited 2021-01-29
|
Different mutation/modification
Different ligand/ion
Different experimental conditions
Different structure-quality metrics
|
Assembly 2
Protein monomer
Monomer;Protein × 1
PDB declaration: monomeric
|
Chain B
26–289(264 aa)
|
Mutation:F72Y
|
No recorded non-water small molecule
|
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, HANGING DROP;pH 4.5;298 K;25% PEG 8,000, 0.1M KsCN, 0.1M Sodium Acetate pH:4.5
|
Resolution 1.81 Å
R-free 0.197
|
|
7LK8
Crystal structure of KPC-2 T215P mutant
Deposited 2021-02-01
|
Different construct
Different mutation/modification
Different ligand/ion
Different experimental conditions
Different structure-quality metrics
|
Assembly 1
Protein monomer
Monomer;Protein × 1
PDB declaration: monomeric
|
Chain A
30–289(260 aa)
|
Mutation:T215P
|
NA SODIUM ION × 2
|
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, HANGING DROP;pH 5.15;298 K;2.5M NaCl, 0.1M Sodium Acetate pH:5.15
|
Resolution 1.43 Å
R-free 0.186
|
|
7LK8
Crystal structure of KPC-2 T215P mutant
Deposited 2021-02-01
|
Different construct
Different mutation/modification
Different ligand/ion
Different experimental conditions
Different structure-quality metrics
|
Assembly 2
Protein monomer
Monomer;Protein × 1
PDB declaration: monomeric
|
Chain B
30–289(260 aa)
|
Mutation:T215P
|
NA SODIUM ION × 1
|
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, HANGING DROP;pH 5.15;298 K;2.5M NaCl, 0.1M Sodium Acetate pH:5.15
|
Resolution 1.43 Å
R-free 0.186
|